IRADIMED (IRMD) CFO converts RSUs to stock and uses 2,319 shares for taxes

Rhea-AI Filing Summary

IRADIMED CORP CFO John Glenn reported routine equity compensation activity. On June 20, 2026, he exercised 5,796 restricted stock units into the same number of common shares. To cover related tax obligations, 2,319 shares of common stock were disposed of as a tax-withholding transaction, not an open-market sale. After these entries, he directly holds 11,937 shares of IRADIMED common stock.

Insider Trade Summary

5,796 shares exercised/converted

Mixed 3 txns

Insider GLENN JOHN

Role CFO

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Units	5,796	$0.00	--
Exercise	Common Stock	5,796	$0.00	--
Tax Withholding	Common Stock	2,319	$92.20	$214K

Holdings After Transaction: Restricted Stock Units — 0 shares (Direct, null); Common Stock — 14,256 shares (Direct, null)

Footnotes (1)

1. Each restricted stock unit represents a contingent right to receive one share of Iradimed Corporation's common stock. The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on June 30, 2023. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.

Key Figures

RSUs converted: 5,796 units Shares for tax withholding: 2,319 shares Holding after tax transaction: 11,937 shares +3 more

6 metrics

RSUs converted 5,796 units Restricted stock units converted to common stock on June 20, 2026

Shares for tax withholding 2,319 shares Common shares disposed of to satisfy tax obligations

Holding after tax transaction 11,937 shares Directly held IRADIMED common stock following the tax-withholding disposition

Holding after RSU conversion 14,256 shares Direct common stock position immediately after RSU conversion, before tax withholding

RSU conversion price $0.00 per unit Restricted stock units converted to common stock at no cash exercise price

Tax disposition reference price $92.20 per share Value used for 2,319-share tax-withholding disposition

Key Terms

Restricted Stock Units, tax-withholding disposition, Equity Incentive Plan

3 terms

Restricted Stock Units financial

"The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

tax-withholding disposition financial

"transaction_action: "tax-withholding disposition" with 2,319 common shares delivered for taxes."

A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.

Equity Incentive Plan financial

"received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan."

An equity incentive plan is a program that gives employees, executives or directors the right to receive company stock or options to buy stock as part of their pay. Think of it as offering slices of future company profit to motivate people to boost long‑term performance; for investors it matters because it can align employee goals with shareholder value but also increases the number of shares outstanding, which can dilute existing ownership.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 06/23/2026 - 09:29 AM Accepted by SEC EDGAR 06/23/2026 - 09:29 AM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

GLENN JOHN

(Last) (First) (Middle)

C/O IRADIMED CORPORATION

12705 INGENUITY DRIVE

(Street)

ORLANDO FLORIDA 32826

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
IRADIMED CORP [ IRMD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CFO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/20/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/20/2026		M		5,796(1)	A	(1)	14,256	D
Common Stock	06/20/2026		F		2,319	D	$92.2	11,937	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	06/20/2026		M			5,796	(2)	(2)	Common Stock	5,796	$0	0	D

Explanation of Responses:

1. Each restricted stock unit represents a contingent right to receive one share of Iradimed Corporation's common stock.

2. The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on June 30, 2023. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.

Remarks:

	/s/ John Glenn	06/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did IRADIMED (IRMD) CFO John Glenn report in this Form 4 filing?

CFO John Glenn reported equity compensation activity involving restricted stock units. He converted 5,796 RSUs into common shares and 2,319 shares were used to satisfy tax obligations, leaving him with 11,937 directly held IRADIMED common shares after the transactions.

Did the IRADIMED CFO sell shares in the open market in this Form 4?

No open-market sale was reported. The 2,319-share disposition was coded as a tax-withholding transaction, meaning shares were delivered to cover tax liabilities tied to vesting, not sold through the market like a typical sale of common stock.

How many IRADIMED shares does CFO John Glenn hold after these transactions?

After these transactions, John Glenn directly holds 11,937 shares of IRADIMED common stock. This reflects the net result of converting 5,796 restricted stock units into shares and using 2,319 shares to satisfy associated tax obligations on June 20, 2026.

What happened to the IRADIMED restricted stock units in this Form 4?

5,796 restricted stock units were converted into 5,796 shares of IRADIMED common stock. The derivative RSU position shown in the filing dropped to zero afterward, indicating those units fully vested and were settled in shares for the CFO on June 20, 2026.

Are the IRADIMED CFO’s transactions related to a compensation plan?

Yes. Footnotes state the restricted stock units were granted under IRADIMED’s 2014 Equity Incentive Plan. These RSUs vest in four equal annual installments starting June 30, 2023, and deliver one share of common stock for each vested unit upon settlement.